Citigroup’s BIO-key International BKYI Stock Holding History

Citigroup’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,035	Closed	-$26.7K	–	5753
2026 Q1	$26.7K	Buy	5,035 +5,034	+503,400%	+$31.3K	﹤0.01%	4747
2025 Q4	$6	Buy	+1	New	+$8	﹤0.01%	5843
2025 Q2	–	Sell	-43	Closed	-$338	–	5656
2025 Q1	$338	Sell	43 -212	-83%	-$2.69K	﹤0.01%	5400
2024 Q4	$4.36K	Buy	+255	New	+$2.48K	﹤0.01%	5476

Citigroup's BKYI Position: Q2 2026 in Review

Citigroup sold out of BIO-key International (BKYI) in Q2 2026, closing a stake of 5,035 shares — an estimated $26.7K sold.

Citigroup first reported a position in BKYI in Q4 2024 and held it in 4 quarters. The position peaked at $26.7K in Q1 2026. 0 funds tracked by Wall St. Rank hold BKYI as of Q2 2026.

Citigroup reported no remaining BIO-key International position as of Q2 2026 after selling out during the quarter.
Citigroup sold 5,035 BIO-key International shares in Q2 2026, an estimated $26.7K.
Citigroup first reported a position in BIO-key International in Q4 2024 and held it in 4 quarters.
Citigroup's BIO-key International position peaked at $26.7K in Q1 2026.
0 funds tracked by Wall St. Rank held BIO-key International as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.